(Q36146850)

12 August 2017

FDA drug safety communications: a narrative review and clinical considerations for older adults (English)

1 reference

12 August 2017

Zachary A Marcum

1

1 reference

12 August 2017

Joseph P Vande Griend

series ordinal

2

1 reference

12 August 2017

Sunny A Linnebur

series ordinal

3

1 reference

12 August 2017

language of work or name

1 reference

8 June 2012

1 reference

American Journal of Geriatric Pharmacotherapy

12 August 2017

1 reference

12 August 2017

10

1 reference

12 August 2017

4

1 reference

12 August 2017

264-271

1 reference

Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Clostridium difficile infection in older adults: a review and update on its management

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Improving the Food and Drug Administration's mandate to ensure postmarketing drug safety

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Statins and the risk of new-onset diabetes: a review of recent evidence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Statin therapy and risk of developing type 2 diabetes: a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Dabigatran versus warfarin in patients with atrial fibrillation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Statin-associated memory loss: analysis of 60 case reports and review of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Selecting the optimum therapeutic dose of serotonin reuptake inhibitors: studies with citalopram.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

Statins: Is It Really Time to Reassess Benefits and Risks?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413741

An assessment of statin safety by hepatologists

5 December 2018

1 reference

12 December 2020

Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease

1 reference

12 December 2020

The use of dabigatran in elderly patients

1 reference

12 December 2020

A Critical Evaluation of the Cardiac Toxicity of Citalopram: Part 1

1 reference

12 December 2020

A Critical Evaluation of the Cardiac Toxicity of Citalopram: Part 2

1 reference

12 December 2020

The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety

1 reference

12 December 2020

Clinical challenges in a patient with dabigatran-induced fatal hemorrhage

1 reference

12 December 2020

Steady-state pharmacokinetics of citalopram in young and elderly subjects

1 reference

12 December 2020

Cardiac safety of citalopram: prospective trials and retrospective analyses

1 reference

12 December 2020

10.1016/J.AMJOPHARM.2012.05.002

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22683398

1 reference